RESOLVYX PHARMACEUTICALS
Resolvyx Pharmaceuticals is developing an entirely new class of medicines called Resolvins. Resolvins are naturally-occurring, small molecule lipid mediators with the potential to treat a wide range of inflammatory diseases. Unlike most anti-inflammatory drugs which suppress the body's inflammatory response, Resolvins work by activating the body's own mechanisms for shutting off, or resolving, inflammation.
RESOLVYX PHARMACEUTICALS
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2001-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.resolvyx.com
Total Employee:
11+
Status:
Active
Contact:
781-541-5045
Email Addresses:
[email protected]
Total Funding:
20.7 M USD
Technology used in webpage:
SPF IPv6 Cloudflare Hosting Cloudflare DNS NameBright
Current Advisors List
Timothy J. Barberich Member of the Board of Directors @ Resolvyx Pharmaceuticals Board_member
Current Employees Featured
James Nichols
James Nichols Chief Executive Officer @ Resolvyx Pharmaceuticals Chief Executive Officer
Daniel Goodman
Daniel Goodman Co-Founder @ Resolvyx Pharmaceuticals Co-Founder
Founder
Daniel Goodman
Investors List
CHL Medical Partners
CHL Medical Partners investment in Series A - Resolvyx Pharmaceuticals
Flagship Pioneering
Flagship Pioneering investment in Series A - Resolvyx Pharmaceuticals
Atlas Venture
Atlas Venture investment in Series A - Resolvyx Pharmaceuticals
Official Site Inspections
http://www.resolvyx.com Semrush global rank: 3.77 M Semrush visits lastest month: 1.18 K
- Host name: li972-44.members.linode.com
- IP address: 45.33.18.44
- Location: Dallas United States
- Latitude: 32.7787
- Longitude: -96.8217
- Metro Code: 623
- Timezone: America/Chicago
- Postal: 75270
Loading ...